Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000671487 | SCV000796464 | uncertain significance | Renal carnitine transport defect | 2017-12-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000671487 | SCV002311162 | uncertain significance | Renal carnitine transport defect | 2021-08-24 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine with glutamic acid at codon 267 of the SLC22A5 protein (p.Gly267Glu). The glycine residue is highly conserved and there is a moderate physicochemical difference between glycine and glutamic acid. This variant is present in population databases (rs775430253, ExAC 0.04%). This variant has not been reported in the literature in individuals affected with SLC22A5-related conditions. ClinVar contains an entry for this variant (Variation ID: 555629). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C15"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Giacomini Lab, |
RCV000671487 | SCV002576675 | uncertain significance | Renal carnitine transport defect | 2022-10-03 | criteria provided, single submitter | research | |
Fulgent Genetics, |
RCV000671487 | SCV002775210 | uncertain significance | Renal carnitine transport defect | 2022-02-01 | criteria provided, single submitter | clinical testing |